Loading…
De Novo Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That both Overlap and Are Distinct from Those Conferring Echinocandin Resistance
SCY-078 is an orally active antifungal whose target is the β-(1,3)-d-glucan synthase (GS). We evaluated the spontaneous emergence of SCY-078-resistant isolates following drug exposure Resistant isolates were analyzed using broth microdilution methodology and sequencing. The kinetic inhibition parame...
Saved in:
Published in: | Antimicrobial agents and chemotherapy 2017-09, Vol.61 (9) |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | SCY-078 is an orally active antifungal whose target is the β-(1,3)-d-glucan synthase (GS). We evaluated the spontaneous emergence of SCY-078-resistant
isolates following drug exposure
Resistant isolates were analyzed using broth microdilution methodology and
sequencing. The kinetic inhibition parameter IC
(50% inhibitory concentration) was also determined from GS complexes. The spectrum of resistance mutations found suggested a partially overlapping but independent binding site for SCY-078 relative to echinocandins on GS. |
---|---|
ISSN: | 0066-4804 1098-6596 |
DOI: | 10.1128/AAC.00833-17 |